Wei Deng

Wei Deng

Auto-generated profile, based on publicly available information

Wei Deng

School of Biomedical Engineering, University of Technology Sydney, Ultimo, NSW 2007, Australia

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2023 in ACS Materials Au
Verified
Journal Article
Open access
MMMeenu Mehta
Meenu Mehta
TBThuy Anh Bui
Thuy Anh Bui
XYXinpu Yang
Xinpu Yang
YAYagiz Aksoy
Yagiz Aksoy
EGEwa M. Goldys
Ewa M. Goldys
WDWei Deng
Wei Deng
Over the past decade, the therapeutic potential of nanomaterials as novel drug delivery systems complementing conventional pharmacology has been widely acknowledged. Among these nanomaterials, lipid-based nanoparticles (LNPs) have shown remarkable pharmacological performance and promising therapeutic outcomes, thus gaining substantial interest in preclinical and clinical research. In this review, we introduce the main types of LNPs used in drug formulations such as liposomes, nanoemulsions, solid lipid nanoparticles, nanostructured lipid carriers, and lipid polymer hybrid nanoparticles, focusing on their main physicochemical properties and therapeutic potential. We discuss computational studies and modeling techniques to enhance the understanding of how LNPs interact with therapeutic cargo and to predict the potential effectiveness of such interactions in therapeutic applications. We also analyze the benefits and drawbacks of various LNP production techniques such as nanoprecipitation, emulsification, evaporation, thin film hydration, microfluidic-based methods, and an impingement jet mixer. Additionally, we discuss the major challenges associated with industrial development, including stability and sterilization, storage, regulatory compliance, reproducibility, and quality control. Overcoming these challenges and facilitating regulatory compliance represent the key steps toward LNP's successful commercialization and translation into clinical settings.

13 July 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
WDWei Deng
Wei Deng
WCWENJIE CHEN
WENJIE CHEN
SCSandhya Clement
Sandhya Clement
Anna GullerAnna Guller
Anna Guller
ZZZhenjun Zhao
Zhenjun Zhao
EGEwa Goldys
Ewa Goldys
Liposomes have been well established as an effective drug delivery system, due to simplicity of their preparation and unique characteristics. However conventional liposomes are unsuitable for the on-demand content release, which limits their therapeutic utility. Here we report X-ray-triggerable liposomes incorporating gold nanoparticles and photosensitizer verteporfin. The 6 MeV X-ray radiation induces verteporfin to produce singlet oxygen, which destabilises the liposomal membrane and causes the release of cargos from the liposomal cavity. This triggering strategy is demonstrated by the efficiency of gene silencing in vitro and increased effectiveness of chemotherapy in vivo. Our work indicates the feasibility of a combinatorial treatment and possible synergistic effects in the course of standard radiotherapy combined with chemotherapy delivered via X-ray-triggered liposomes. Importantly, our X-ray-mediated liposome release strategy offers prospects for deep tissue photodynamic therapy, by removing its depth limitation.

1 August 2024 in EBioMedicine
Verified
Journal Article
Open access
TBThuy Anh Bui
Thuy Anh Bui
HMHaoqi Mei
Haoqi Mei
RSRui Sang
Rui Sang
DODavid Gallego Ortega
David Gallego Ortega
WDWei Deng
Wei Deng
The Chimeric Antigen Receptor (CAR) T cell therapy has emerged as a ground-breaking immunotherapeutic approach in cancer treatment. To overcome the complexity and high manufacturing cost associated with current ex vivo CAR T cell therapy products, alternative strategies to produce CAR T cells directly in the body have been developed in recent years. These strategies involve the direct infusion of CAR genes via engineered nanocarriers or viral vectors to generate CAR T cells in situ. This review offers a comprehensive overview of recent advancements in the development of T cell-targeted CAR generation in situ. Additionally, it identifies the challenges associated with in vivo CAR T method and potential strategies to overcome these issues.

28 January 2016 in Scientific Reports
Verified
Journal Article
Open access
SCSandhya Clement
Sandhya Clement
WDWei Deng
Wei Deng
ECElizabeth Camilleri
Elizabeth Camilleri
BWBrian Wilson
Brian Wilson
EGEwa Goldys
Ewa Goldys
Singlet oxygen is a primary cytotoxic agent in photodynamic therapy. We show that CeF3 nanoparticles, pure as well as conjugated through electrostatic interaction with the photosensitizer verteporfin, are able to generate singlet oxygen as a result of UV light and 8 keV X-ray irradiation. The X-ray stimulated singlet oxygen quantum yield was determined to be 0.79 ± 0.05 for the conjugate with 31 verteporfin molecules per CeF3 nanoparticle, the highest conjugation level used. From this result we estimate the singlet oxygen dose generated from CeF3-verteporfin conjugates for a therapeutic dose of 60 Gy of ionizing radiation at energies of 6 MeV and 30 keV to be (1.2 ± 0.7) × 108 and (2.0 ± 0.1) × 109 singlet oxygen molecules per cell, respectively. These are comparable with cytotoxic doses of 5 × 107–2 × 109 singlet oxygen molecules per cell reported in the literature for photodynamic therapy using light activation. We confirmed that the CeF3-VP conjugates enhanced cell killing with 6 MeV radiation. This work confirms the feasibility of using X- or γ- ray activated nanoparticle-photosensitizer conjugates, either to supplement the radiation treatment of cancer, or as an independent treatment modality.

22 March 2013 in Physical Chemistry Chemical Physics
Verified
Journal Article
Closed access
PDF file
WDWei Deng
Wei Deng
XFXie Fang
Xie Fang
HBHenrique T. M. C. M. Baltar
Henrique T. M. C. M. Baltar
EGEwa Goldys
Ewa Goldys
We discuss the phenomenon of enhanced fluorescence in the proximity of metal nanostructures addressing the question of how much fluorescence signal can be obtained from fluorophores in such altered environments. We review its applicability for the methodologies used in the life science, such as immunoassays, flow cytometry and bioimaging. Experimental and theoretical scenarios employing various metal nanostructures – such as homogeneous enhancing substrates, fluorescence-enhancing microbeads, and metal core–dielectric shell nanocomposites – are described.